Advent Technologies (ADN) Reports Q4 Loss of $0.26/sh

Go back to Advent Technologies (ADN) Reports Q4 Loss of $0.26/sh

Advent Technologies Reports Q4 2022 Results

March 31, 2023 7:00 AM EDT

Q4 2022 revenue of $2.0 million and income from grants of $0.4 million.  Full year 2022 revenue of $7.8 million and income from grants of $1.5 million. Net loss in Q4 of $47.6 million or $(0.92) per share, including an impairment charge of $38.9 million.  Adjusted net loss in Q4 of $13.2 million or $(0.26) per share. Company holds unrestricted cash reserves of $32.9 million as of December 31, 2022. After official ratification from the European Commission of the European Union for funding of 782.1 million under the Important Projects of Common European Interest (IPCEI) Hydrogen Technology for Advents Green HiPo project, Advent has been working... More